1.23
+0.01(+0.82%)
Currency In USD
| Previous Close | 1.22 |
| Open | 1.24 |
| Day High | 1.24 |
| Day Low | 1.2 |
| 52-Week High | 2.55 |
| 52-Week Low | 0.69 |
| Volume | 91,841 |
| Average Volume | 371,739 |
| Market Cap | 1.16M |
| PE | -1.58 |
| EPS | -0.78 |
| Moving Average 50 Days | 1.26 |
| Moving Average 200 Days | 1.56 |
| Change | 0.01 |
If you invested $1000 in Chemomab Therapeutics Ltd. (CMMB) since IPO date, it would be worth $7.12 as of May 09, 2025 at a share price of $1.23. Whereas If you bought $1000 worth of Chemomab Therapeutics Ltd. (CMMB) shares 5 years ago, it would be worth $69.57 as of May 09, 2025 at a share price of $1.23.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Chemomab Announces Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis in Distinguished Plenary Session at DDW 2025
GlobeNewswire Inc.
May 05, 2025 12:00 PM GMT
SPRING Trial Data Presented at Digestive Disease Week® 2025 Shows that Nebokitug at 15 and 48 Weeks of Treatment Is Well-Tolerated and Associated with Significant Improvements in Multiple Fibrotic and Inflammatory Biomarkers that Represent Slowing of
Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug’s Impact in Primary Sclerosing Cholangitis and Related Diseases
GlobeNewswire Inc.
Apr 28, 2025 12:00 PM GMT
New Analyses of PSC Data from Phase 2 SPRING Trial Show that Treatment with Nebokitug Is Associated with Dose-Dependent and Significant Improvements in Multiple Inflammatory and Fibrotic Biomarkers Further Confirms the Clinical Potential of Nebokitug
Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences
GlobeNewswire Inc.
Apr 21, 2025 12:00 PM GMT
TEL AVIV, Israel, April 21, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics, Ltd., (Nasdaq: CMMB), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that c